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Coordination between cell fate specification and cell cycle control in multicellular organisms is essential to regulate cell
numbers in tissues and organs during development, and its failure may lead to oncogenesis. In mammalian cells, as part
of a general cell cycle checkpoint mechanism, the F-box protein -transducin repeat-containing protein (-TrCP) and the
Skp1/Cul1/F-box complex control the periodic cell cycle fluctuations in abundance of the CDC25A and B phosphatases.
Here, we find that the Caenorhabditis elegans -TrCP orthologue LIN-23 regulates a progressive decline of CDC-25.1
abundance over several embryonic cell cycles and specifies cell number of one tissue, the embryonic intestine. The
negative regulation of CDC-25.1 abundance by LIN-23 may be developmentally controlled because CDC-25.1 accumulates
over time within the developing germline, where LIN-23 is also present. Concurrent with the destabilization of CDC-25.1,
LIN-23 displays a spatially dynamic behavior in the embryo, periodically entering a nuclear compartment where CDC-25.1
is abundant.
INTRODUCTION
Integration of developmental fate specification and control
of the eukaryotic cell cycle is essential to regulate cell num-
ber in tissues and organs. The eukaryotic cell cycle is driven
by cyclin-dependent kinases, whose activation requires the
removal of inhibitory phosphates by Cdc25 phosphatases
(Boutros et al., 2006). We described previously an intestinal-
specific hyperplasia of Caenorhabditis elegans caused by cdc-
25.1(ij48), a gain-of-function mutation causing the amino
acid substitution CDC-25.1(S46F), where S46 is within a
putative aspartic acid-serine-glycine (DSG) phosphorylation
site that is also a consensus glycogen synthase kinase (GSK)3
phosphorylation site (Clucas et al., 2002). A similar mutant
CDC-25.1(G47D) was identified independently of our study
(Kostic and Roy, 2002). Because CDC-25.1 function is re-
quired in probably all early C. elegans cell types to drive
normal proliferation (Ashcroft et al., 1999; Clucas et al., 2002),
the intestinal-specific phenotype of these mutants suggests
interplay between intestinal fate specification and cell cycle
control regulated by CDC25.1.
In cultured mammalian cells, ubiquitin-mediated proteolysis
by the F-box protein -transducin repeat-containing protein
(-TrCP), a component of the Skp1/Cul1/F-box (SCF) ubiq-
uitin ligase, has been shown to control the periodic cell cycle
fluctuations and DNA damage response through abundance of
CDC25A and B via DSG and aspartic acid-aspartic acid-glycine
(DDG) motifs, respectively (Busino et al., 2003; Jin et al., 2003).
Also, elevated CDC25A/B protein levels have been detected in
many human malignancies (Kristjansdottir and Rudolph,
2004). A similar regulatory process exists in the Wnt pathway
where the adenomatous polyposis coli (APC)/Axin/GSK3
destruction-box complex phosphorylates the DSG motif of
human -catenin, promoting its -TrCP–dependent ubiquiti-
nation and proteasomal degradation (Kikuchi et al., 2006). Mu-
tations in either APC or the -catenin DSG motif cause stabili-
zation of -catenin and are associated with human intestinal
hyperplasia and oncogenesis (Polakis, 2000; Ougolkov et al.,
2004; Gregorieff and Clevers, 2005). Therefore, we tested
whether the intestinal hyperplasia caused by the C. elegans
CDC-25.1(S46F) DSG mutant was the result of an abrogation of
its -TrCP or APC/GSK3-dependent regulation.
The C. elegans intestine consists of 20 cells derived from a
single founder cell termed E (Sulston et al., 1983). The pa-
rental cell of E is the pluripotent EMS blastomere, and its
division is considered a binary decision between two devel-
opmental fates, its anterior daughter-cell MS (mesoderm)
and posterior daughter-cell E (endoderm/intestine). This
pluripotent capacity of EMS is sometimes described as mes-
endoderm. Specification of E as endoderm depends on a
Wnt signal from the P2 blastomere. Isolation of EMS from
the P2-derived Wnt signal causes two MS-like daughters to
be born (Goldstein, 1993, 1995) and mutations that block the
Wnt pathway cause the same E-to-MS fate transformation
(Rocheleau et al., 1997, 1999; Thorpe et al., 1997; Schlesinger
et al., 1999; Maduro et al., 2001; Bei et al., 2002). In the
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canonical Wnt pathway that regulates human intestinal de-
velopment, Wnt-activated Frizzled causes negative regula-
tion of GSK3, resulting in stabilization of -catenin; hence,
loss of GSK3 activity would mimic constitutive activation
of the Wnt signal and have an opposite phenotype to loss of
positive-acting pathway members (Kikuchi et al., 2006).
However, during endodermal fate specification in C. elegans,
interference of gsk-3 (GSK3) has been interpreted as caus-
ing the same phenotype as loss of positive-acting Wnt mem-
bers. To explain this enigma, in this one case GSK3 has been
proposed to be activated in response to reception of the Wnt
signal, although no known molecular mechanisms or bio-
chemical data exist to support this hypothesis (Korswagen,
2002). Among the outcomes of endodermal fate specification
is a change in the regulation of the cell cycle. The intestinal
cells have a significantly longer cell cycle to those of the
sister MS lineage and to most other early embryonic lin-
eages. This is believed to be the result of the inclusion of a
Gap phase in the intestinal lineage (Edgar and McGhee,
1988).
We find the C. elegans -TrCP orthologue LIN-23 regulates
CDC-25.1 abundance negatively in all early embryonic tis-
sues; the negative regulation of CDC-25.1 by LIN-23 in the
embryo was also concluded from a recent genetic analysis
(Hebeisen and Roy, 2008). Although CDC-25.1 is destabi-
lized by LIN-23 in most or all early embryonic tissues, we
find those cells specified as intestine, either by normal de-
velopment or ectopically, are particularly sensitive to failure
of this down-regulation. In addition to causing the intestinal
hyperplasia, interference of lin-23 function in the embryo
significantly shortens the long intestinal cell cycle but does
not shorten the already short MS lineage cell cycle. By in-
vestigating cell lineage defects caused by gsk-3(RNAi), we
were able to show that long intestinal cell cycles created
ectopically by the transformation of another cell lineage by
gsk-3(RNAi) were equally sensitive to cell cycle shortening
by stabilization of CDC-25.1 as those of the normal intestinal
lineage. We conclude that endodermal fate specification and
not lineage of descent must determine the switch to the long,
Gap phase-containing cell cycles of the C. elegans intestine
and their concomitant switch to sensitivity to LIN-23–de-
pendent regulation of CDC-25.1. This regulatory mechanism
is therefore a significant rate-limiting step in the long intes-
tinal cell cycles but not in the majority of other short embry-
onic cell cycles such as those of the MS lineage.
We find evidence that the regulation of CDC-25.1 by
LIN-23 is developmentally controlled. Here, we demon-
strate that lin-23 acts as a maternal gene with respect to its
embryonic functions including the degradation of CDC-25.1;
we demonstrated previously that cdc-25.1 is also maternal
for embryonic function (Clucas et al., 2002). In this study, we
show that both LIN-23 and CDC-25.1 proteins are present in
the maternal germline and that at the time of fertilization the
oocyte contains both proteins maternally derived. Although
maternally derived LIN-23 promotes the rapid decline in
abundance of maternally derived CDC-25.1 in probably all
cells of the early embryo, within the maternal germline
CDC-25.1 accumulates in the presence of LIN-23. Finally,
we find that the subcellular localization of LIN-23 be-
comes dynamic in the early embryo concurrent with the
onset of CDC-25.1 destabilization, where we detect its
periodic localization to the nucleus. Because LIN-23 seems
to be excluded from nuclei within the germline, it is
interesting to speculate whether its periodic nuclear lo-
calization in the early embryo is related to its destabiliza-
tion of CDC-25.1, which is predominantly nuclear local-
ized in the cells of the early embryo.
MATERIALS AND METHODS
C. elegans Strains
C. elegans strains used in this study were N2 Bristol, JR1838 wIs84[pJM66
elt-2::GFP::LacZ, pRF4 rol-6(su1006dm)] (intestinal green fluorescent protein
[GFP]), IA105 unc-76(e911)V; ijIs12[dpy-7::GFP::lacZ, unc-76()] (hypodermal
GFP), JR667 unc-119(e2498::Tc1)III; wIs51[pMF1, pDP#MM016B unc-119()]
(seam cell GFP), IA522 unc-76(e911)V; ijEx31[elt-2::LAP::cdc-25.1, p76-16B unc-
76()], IA530 cdc-25.1(ij48)I; wIs84, IA535 ijIs16[elt-2::LAP::cdc-25.1, p76-16B
unc-76()], IA565 lin-23(e1883)/II; wIs119[pDP#MM016B unc-119(),
pMW025 (npa-1::GFP::LacZ)], IA568 lin-23(e1883)/I; wIs84, IA582 unc-
119(ed3)III; ijIs18 [lin-23::FLAG-TY, unc-119()], IA589 lin-23(e1883)II; unc-
119(ed3)III; ijIs18 [lin-23::FLAG-TY, unc-119()], IA592 lin-23(e1883)II; ijIs18
[lin-23::FLAG-TY, unc-119()]; wIs84, IA593 cdc-25.1(ij48)I; lin-23(e1883)II;
ijIs18[lin-23::FLAG-TY, unc-119()]; wIs84. CB3514 lin-23(e1883)/dpy-10(e128)II
and DP38 unc-119(ed3) were obtained from the C. elegans Genetics Stock Center
(University of Minnesota, Twin Cities, MN), which is funded by the National
Institutes of Health National Center for Research Resources. JR1838 and JR667
were kindly supplied by Joel Rothman (Department of Molecular, Cellular, and
Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA).
Plasmid Constructs
The plasmid pAS10 (pBS-unc119-lin-23::FLAG-TY) contains a FLAG-tagged
and TY epitope-tagged transgene of lin-23 fused to upstream sequences of
lin-23 necessary for its expression, plus a copy of the unc-119 gene that is
used for selection of integrative transgenesis. pAS11 (pGEX6P-lin-23) is a
GST::lin-23 cDNA expression clone, and pAS5 (pQE30-cdc-25.1) is a
HIS6::cdc-25.1 cDNA clone used for recombinant LIN-23 or CDC-25.1
protein synthesis.
Genomic lin-23 was cloned using the oligonucleotides (oligos) 5-GGTAC-
CCCAAATTTGCCTCTGATTCCG and 5-GGTACCGTTGCAGAAAT GCT-
CAAATCGG to clone 2183 base pairs of upstream promoter, the complete lin-23
gene, and 766-base pair 3 untranslated region (UTR) into the KpnI site of pBS-SK
(Stratagene, La Jolla, CA) to generate pAS7 (pBS-lin-23). For lin-23::FLAG-TY, the
following oligos were used to insert the FLAG and TY tag in frame at the 3 end
of the lin-23 genomic DNA as BamHI, SpeI fragments using oligos 5-ACT-
AGTCTTGTCGTCGTCATCCTTGTAGTCTGGGCCACCATCTGGCATC-
TCTTC, 5-ACTAGTGAGGTCCATACTAACCAGGACCCACTTGACTAA-
AATCTACACTCCTTCCCATTTT, and 5CGACGAGGAATTGCATGTCTTC
and M13rev and cloned into pAS7 cut with BamHI to generate pAS8
(pBS-lin-23::FLAG-TY). A 5.7-kb unc-119 gene XbaI/HindIII cassette was cloned
as XbaI/HindIII cassette into pBS-SK and the lin-23::FLAG-TY subsequently
inserted as a KpnI fragment to generate pAS10 (pBS-unc-119-lin-23::FLAG-TY).
GST::lin-23 was cloned by amplification of the lin-23 cDNA by using oligos
5-CCCGGGTTCTTCACCGCACCGAGCTTCAAC and 5-CCCGGGTTAT-
GGGCCACCATCTGGCATCTC and insertion as SmaI fragment into pGEX6P1
(GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) to generate
pAS11 (pGEX6P-lin-23). A 797-base pair BamHI lin-23 cDNA fragment was
cloned into pQE80L (QIAGEN, Dorking, Surrey, United Kingdom) to generate
HIS6::lin-23-C-terminus [pAS14 (pQE80L-lin-23-C)]. 5-GGATCCGCTACCAC-
CGGGGAAAAAGC and 5-GAGCTCTTATTCGGCGTCGTCAGAAAT oligos
were used to clone cdc-25.1 cDNA as BamHI/SacI fragment into pQE30 (QIAGEN)
to generate HIS6::cdc-25.1 [pAS5 (pQE30-cdc-25.1)].
The plasmid pAS1 (pBS-elt-2::LAP::cdc-25.1) contains an LAP (GFP-S-tag-
TEV cleavage site) tagged cdc-25.1 transgene fused to the elt-2 promoter.
The 5068-base pair elt-2 promoter fragment was amplified by polymerase
chain reaction (PCR) with the oligos 5-TTTTCTCGAGCGAGCTGAATA-
CACGTGCT and 5-TTTTGGATCCTCTATAATCTATTTTCTAGTTTC (from
the pJM69 vector; a gift from J. McGhee, University of Calgary, Calgary, AB,
Canada). PCR amplification of a 2569-base pair cdc-25.1 genomic DNA fragment
was done using the oligos 5-TTTTGGATCCGCTACCACCGGGGAAAAAGC
and 5-TTTTTCTAGAGCTGAGATTAATGTGAACGC; this fragment starts at
the first codon following the cdc-25.1 ATG and includes 478 base pairs of 3UTR.
The fragments were cut with XhoI/BamHI (elt-2) and BamHI/XbaI (cdc-25.1) and
inserted into pBS-SK that was digested with XhoI and XbaI. The resulting vector
was subsequently digested with BamHI and the LAP tag (GFP-S-tag-TEV cleav-
age site) inserted in frame as a 1086-base pair BamHI fragment that was derived
from BamHI digestion of the pIC26 vector (a gift from I. Cheeseman, Whitehead
Institute for Biomedical Research, Cambridge, MA).
Chromosomal Integration of Extrachromosomal
Transgenes
By a standard procedure, IA522 animals were irradiated with 3800 rad by using
a 60Co source to integrate the extrachromosomal array ijEx31[elt-2::LAP::cdc-25.1,
p76-16B unc-76()], selecting for unc-76 rescued worms. This generated several
stably integrated lines. One line was selected for use and backcrossed four
times against N2 to remove potential and unwanted mutations, generating
the strain IA535.
Microparticle Bombardment
Integration of lin-23::FLAG-TY was done by microparticle bombardment of
DP38 unc-119(ed3) essentially as described by Praitis et al. (2001), using NotI
A. Segref et al.
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linearized pAS10. NonUnc larvae were selected and several strains were
analyzed for germline expression of LIN-23::FLAG-TY. One strain that dis-
played expression of tagged LIN-23::FLAG-TY protein in the germline was
selected for further analysis to generate IA589, IA592, and IA593.
RNA Interference (RNAi)
C. elegans GSK3 genes were identified from the literature (Schlesinger et al.,
1999) and by BLAST searches. The genes selected were gsk-3 (Y18D10A.5),
which is probably orthologous and C44H4.6, a GSK3 family member. lin-23 is
orthologous to human -TrCP and sel-10 is the next most closely related
(Kipreos et al., 2000). The C. elegans cullins, pop-1, and apr-1 were all identified
from the literature (Kipreos et al., 1996; Rocheleau et al., 1997). The following
genomic fragments (relative to the genomic ATG) were cloned into the
pPD129.36 vector: lin-23 (K10B2.1), 685-1811 base pairs* and 1812-2686
base pairs; gsk-3 (Y18D10A.5), 1266-2940 base pairs; cullin-1 (D2045.6),
238-1234 base pairs*; cullin-2 (ZK5204), 1990-3100 base pairs; sel-10
(F55B12.3), 796-3010 base pairs*; pop-1 (W10C8.2), 5171-6847 base pairs*;
apr-1 (K04G2.8), 2696-4615 base pairs; and C44H4.6, 1319-3018 base pairs. The
clones indicated with an asterisk were obtained from the RNAi library (Ka-
math and Ahringer, 2003). For apr-1(RNAi), the apr-1 clone was in vitro
transcribed to generate double-stranded RNA for microinjection. Other clones
were used for bacterial feeding RNAi by using established procedures (Fraser
et al., 2000; Timmons et al., 2001). Where RNAi was performed in liquid
culture, RNAi bacterial strains were grown overnight in Luria-Bertani (LB)
medium containing 100 g/ml ampicillin at 37°C. The cultures were then
diluted to an OD600 of 0.6 in a final volume of 500 ml of LB containing 100
g/ml ampicillin and 1 mM isopropyl -d-thiogalactoside (IPTG) and dou-
ble-stranded RNA induced at 37°C for 4 h. The cultures were spun down at
4000  g for 10 min, and the bacterial pellets were used to inoculate 250 ml of
S-medium containing 50 g/ml ampicillin and 0.2 mM IPTG. Starved L1-
staged hermaphrodites were added to 250 ml of lin-23, gsk-3, or control RNAi
S-medium and incubated for 3 d at 25°C. For lin-23 or sel-10, RNAi, embryos
were applied to RNAi plates, grown to adulthood at 25°C, and the phenotype
was observed in their offspring. L4 hermaphrodites were fed for 24 h in pop-1
and cul-2 RNAi or for 48 h for gsk-3 and cul-1 RNAi at 25°C, and their
offspring analyzed for intestinal phenotypes. RNAi of apr-1 was performed by
microinjection of in vitro-transcribed double-stranded 1919-base pair apr-1
RNA into young adult hermaphrodites, and the phenotype was observed
after incubation at 20°C for 24 h. Typically, 12% of all (40% of RNAi-
arrested) embryos displayed intestinal hyperplasia. RNAi was performed in
C. elegans liquid culture for subsequent protein extraction from embryos. Em-
bryos were collected using the standard bleach method (Sulston and Hodgkin,
1988), lysed in lysis buffer (see Immunoprecipitation), and equal amounts of total
protein were resuspended in sample buffer and applied to SDS-polyacrylamide
gel electrophoresis (PAGE) followed by Western blotting.
Antibodies
Antibodies were raised against recombinant LIN-23 and CDC-25.1. The plas-
mid clones used were pAS5 (pQE 30-cdc-25.1) and pAS11 (pGEX6P-lin-23).
pAS5 was constructed by amplifying by PCR a 1815-base pair cDNA
sequence of cdc-25.1 with the oligonucleotides 5-TTTTGGATCCGCTAC-
CACCGGGGAAAAAGC-3 and 5-TTTTGAGCTCTTATTCGGCGTCGTCA-
GAAAT-3. After restriction digestion with BamHI and SacI, the fragment
was cloned into pQE30. A 1995-base pair lin-23 cDNA fragment (lacking the
endogenous ATG) was PCR amplified using the oligonucleotides 5-TTTTC-
CCGGGTTCTTCACCGCACCGAGCTTCAAC-3 and 5-TTTTCCCGGGT-
TATGGGCCACCATCTGGCATCTC-3. The amplified fragment was di-
gested with SmaI and inserted in frame into the SmaI site of pGEX-6P-1. The
HIS6::CDC-25.1 and GST::LIN-23 proteins were used to immunize rabbits
(SNBTS, Scotland). For affinity purification of antibodies, the recombinant
proteins in 4 M urea and 0.1 M sodium borate, pH 8.3, were cross-linked to
activated CNBr-Sepharose (GE Healthcare) according to manufacturer’s in-
structions. Each rabbit serum, diluted in an equal volume of phosphate-
buffered saline (PBS) was incubated overnight at 4°C with the appropriate
recombinant protein cross-linked to CNBr-Sepharose. The beads were subse-
quently poured into a 10-ml Poly-Prep column (Bio-Rad Laboratories, Hemel
Hempstead, United Kingdom), and the flow-through was collected. The
antibody, bound to the beads, was washed once with 10 ml of wash buffer (1
PBS-Tween 20 at 0.1%), followed by three washes with 10 ml of 1 PBS.
Bound antibodies were eluted with 10 ml of elution buffer (100 mM glycine
and 200 mM NaCl, pH 2.2), and 1-ml fractions were collected on ice in 1.5-ml
microcentrifuge tubes containing 200 l of 1 M Tris, pH 8.0, to neutralize the
acidic pH from the elution buffer. The OD280 of all fractions were measured,
and those with the highest antibody concentrations were pooled. Antibodies
were precipitated with 50% ammonium sulfate, suspended in PBS-Glycerol
(PBS-G), and further dialyzed against 1 PBS-G at 8.7% for 10 h at 4°C.
Anti-CDC-25.1 peptide antibodies used for immunostaining or Western blot-
ting were as described previously (Clucas et al., 2002).
Immunoprecipitation and Western Blotting
Immunoprecipitation from embryonic extracts or L4-stage hermaphrodites
was essentially done as described in Desai et al. (2003), with slight modifica-
tions. In brief, for embryonic extracts, C. elegans L1 larvae were grown in
large-scale liquid S-medium cultures to adulthood. Embryos were collected
using the standard bleach method (Sulston and Hodgkin, 1988) and sus-
pended in lysis buffer (50 mM Tris, pH 7.5, 100 mM KCl, 1 mM EDTA, 1 mM
MgCl2, 8.7% glycerol, 0.05% NP-40, 1 Protease Inhibitor Cocktail [Roche
Diagnostics, Mannheim, Germany], and 1 Phosphatase Inhibitor Cocktail I
and II [Sigma Chemical, Poole, Dorset, United Kingdom]), quickly frozen in
liquid nitrogen, and lysed by sonication using an Ultrasonic processor with
5-mm microtip (Jencons, Leyton Buzzard, United Kingdom) for 10 pulses over
10 s at 30% amplitude. Where L4-stage hermaphrodites were used, L1 worms
were grown as described above, and worms were collected before they
reached adulthood at the early to late L4 stage and lysed in lysis buffer (as
performed for embryos). After sonication, extracts were precleared by cen-
trifugation at 30,000  g for 20 min at 4°C. The precleared extract (300 g of
total protein) was incubated with 40 g of anti-CDC-25.1 affinity-purified
antibody (this study) cross-linked to protein A-agarose (Bio-Rad Laborato-
ries), or as control, a similar amount of rabbit immunoglobulin (Ig)G (Sigma
Chemical) cross-linked to protein A-agarose was used in a total volume of 200
l of lysis buffer containing 1% NP-40, the inclusion of which reduced
nonspecific binding of proteins to the matrix. The samples were rotated for 1 h
at 4°C, the beads were washed three times with lysis buffer, and eluted with
30 l of glycine/HCl and 200 mM NaCl, pH 2.2. After immunoprecipitation,
eluates were diluted in 30 l of SDS sample buffer, heated to 95°C for 4 min,
and typically 3% of total for input and 30% for the eluates were applied to
SDS-PAGE followed by Western blotting with anti-CDC-25.1 (1:400;
Clucas et al., 2002), anti-LIN-23 (1:750), anti-ubiquitin (1:1000; Covance
Research Products, Princeton, NJ), anti-GSK3 (1:500; Sigma Chemical), or
anti--actin (1:2000; Sigma Chemical) antibodies. Where extracts were not
subjected to immunoprecipitation (see Figures 2, A and B, and 3B), the
same amount of total protein derived from those extracts was resuspended
in SDS sample buffer, heated to 95°C as described above, and then directly
applied to SDS-PAGE and analyzed by Western blotting. In Figure 5,
worms were first collected in 1 M9 buffer, resuspended in SDS sample
buffer, heated at 95°C, and applied to SDS-PAGE analysis followed by
Western blotting.
Purification of LAP::CDC-25.1 on S-Protein Agarose
Embryos were prepared as described under Immunoprecipitation. Embryos
were lysed in lysis buffer (50 mM Tris, pH 7.5, 300 mM KCl, 1 mM EDTA,
0.05% NP-40, 1 Protease Inhibitor Cocktail [Roche Diagnostics], and 1
Phosphatase Inhibitor Cocktail I and II (Sigma Chemical). Sixty micrograms of
S-protein agarose (Novagen, Madison, WI) was washed once with 400 l of
lysis buffer. Three hundred micrograms of total protein in lysis buffer was
incubated with the washed S-protein agarose in a total volume of 200 l; 10
l was kept aside as input control. The mixture was incubated in a 1.5-ml
microcentrifuge tube for 3 h at 4°C with continuous end-over-end rotation,
the flow-through was collected, and the beads were washed three times with
400 l of lysis buffer. The samples were eluted for 3 min at room temperature
in 60 l of SDS sample buffer followed by 4-min incubation at 95°C. A fraction
of the input and flow-through was suspended in equal volume of SDS sample
buffer and boiled at 95°C for 4 min. Five microliters of the input and flow-
through and 20 l of the eluate were applied to 10% SDS-PAGE to probe with
anti-GFP or anti-LIN-23 antibodies.
Conventional Microscopy for Live Imaging
Live imaging was performed according to Sulston and Hodgkin (1988) by
using an Axioplan 2 microscope (Carl Zeiss, Jena, Germany) equipped
with Nomarski optics using the 63/1.4 Plan-Apochromat lens. GFP
fluorescence was viewed using a tungsten halogen lamp UV source at 488
nm. Images were taken with a C4742-95 digital camera (Hamamatsu
Photonic, Hamamatsu City, Japan) and Openlab 4.0.2. software (Improvi-
sion, Coventry, United Kingdom). Images were processed using Photo-
shop 8.0 and Illustrator 12 (Adobe Systems, Mountain View, CA) for figure
assembly.
Cell Lineage Analysis
Four-dimensional microscopy for cell lineage analysis was as described in
Schnabel et al. (1997). Lineages are derived from embryos cultured at 25°C.
RNAi was performed by the bacterial feeding method as described above. The
C. elegans strains used were JR1838 and IA530.
Immunocytochemistry
Immunostaining of CDC-25.1 was performed as described previously (Clucas
et al., 2002), with the exception that anti-CDC-25.1 peptide antibody was used
at 1:150 dilution and embryos were analyzed using an LSM 510 META
confocal microscope (Carl Zeiss) at 405 nm and 543 nm for 4,6-diamidino-2-
phenylindole (DAPI; Vector Laboratories, Burlingame, CA) and Alexa Fluor
594 (Invitrogen, Paisley, United Kingdom), respectively. Samples were exam-
ined using 63/1.4 Plan Apochromat lens and 2 optical zoom. Typical
settings for nonstacked images were 1012 frame size, line-step: 1, maximum
scan speed, 12 bit data depth, scan direction: single, mode: line, method: mean
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with average between 2 and 8 numbers. Images were taken using LSM 510
Meta version 3.2.SP2 imaging software (Carl Zeiss). Identical settings were
used for comparative imaging of wild-type (WT) and mutant or control and
RNAi-treated embryos at each developmental stage according to the manu-
facturer’s instructions. The developmental stages were determined by count-
ing the number of nuclei per embryo as revealed through DAPI staining. Due
to the fast decay of CDC-25.1 from early-to-late stages of embryogenesis, the
detector gain was adjusted accordingly to keep the linearity of the signal. For
fluorescence quantification, the embryo was selected using LSM 510 software,
the signal was extracted, and the average values of fluorescence intensities
were compared. All images were processed with equivalent settings for figure
assembly using Photoshop 8.0 (Adobe Systems).
In LIN-23 immunostaining, the anti-LIN-23 antibody was diluted 1:600
followed by Alexa Fluor 594. Samples were viewed at 543 nm (Alexa Fluor
594) or 405 nm (DAPI) using an Axioplan 2 microscope (Carl Zeiss), and
images were obtained as described under Conventional Microscopy for Live
Imaging.
Statistics
The fluorescence intensity of anti-CDC-25.1–immunostained embryos was
measured as described above and analyzed using standard statistical tech-
niques (Sokal and Rohlf, 2000; Supplemental Table 2).
RESULTS
C. elegans SCF-TrCP Complex Members Regulate
Intestinal Cell Number via CDC-25.1
We hypothesized the intestinal hyperplasia caused by the
CDC-25.1(S46F) mutant might be by escape from negative
regulation and predicted RNAi knockdown of component
regulators might mimic its phenotype. We tested by RNAi
members of the SCF-TrCP and APC/Axin/GSK3 com-
plexes. Previously, null mutants of the C. elegans -TrCP and
CUL1 orthologues lin-23 and cul-1 were shown to cause
hyperplasia of several postembryonic tissues, but no embry-
onic intestinal cell proliferation defects were reported
(Kipreos et al., 1996, 2000); however, maternal products of
these may persist in null-mutant embryos. RNAi can knock-
down both maternal and zygotic gene function (Fire et al.,
1998) in C. elegans, and we found that lin-23 or cul-1 RNAi
generated a hyperplasia of the intestine during embryogen-
esis (Figure 1A and Table 1A). To test genetically whether
lin-23 and cul-1 function through CDC-25.1 S46, we repeated
the RNAi in a cdc-25.1(ij48) mutant; no synergism was de-
tected (Table 1A). Because these are nonadditive, we con-
clude it most likely that lin-23 and cul-1 function through
CDC-25.1 S46 to regulate intestinal cell number. A similar
interpretation of the lin-23–dependent regulation of CDC-
25.1 controlling intestinal cell proliferation in the developing
C. elegans embryo has been reported previously (Hebeisen
and Roy, 2008).
We obtained additional corroborating data from the be-
havior of a lin-23 transgene. We generated a lin-23::
FLAG-TY (ijIs18) chromosomally integrated transgene for
use in a biochemical analysis of the interaction between
CDC-25.1 and LIN-23 (see below). The original strain IA582
is homozygous for the wild-type lin-23 allele at its native
chromosomal locus and for the genetically unlinked chro-
mosomal integration of the epitope-tagged lin-23::FLAG-TY
transgene; thus, both wild-type and epitope-tagged LIN-23
are present. This strain is healthy with no detectable lethal-
ity; thus, the site of integration does not interrupt an essen-
tial gene, and the LIN-23::FLAG-TY protein does not have a
noticeable negative effect on wild-type LIN-23 function. To
generate a strain in which the only LIN-23 function was of
the lin-23::FLAG-TY transgene, we crossed the transgene
into a strain with the chromosomal allele lin-23(e1883), a
strong loss of function and presumed null (Kipreos et al.,
2000). The resulting strains that are homozygous for lin-
23(e1883) and ijIs18 display a variably penetrant lethality
where 75% of animals die during embryogenesis (see
below). Animals homozygous for lin-23(e1883) proceed
through embryogenesis normally but then display excess
cell proliferation in various postembryonic cell lineages and
develop as sterile adults. Thus, lin-23(e1883) homozygotes
are derived from heterozygous mothers and as we demon-
strate below, have some maternally supplied lin-23 function.
Because in C. elegans RNAi can target both zygotic and
maternal gene function, where maternal gene function ex-
ists, RNAi can generate embryonic phenotypes that are
not seen in homozygous mutants. In addition to the em-
bryonic hyperplasia discussed above, we find lin-23 RNAi
also causes embryonic lethality; when performed by the
bacterial feeding method, 25% of the resulting embryos
Figure 1. C. elegans excess endoderm pheno-
types. (A) Left, GFP fluorescence of JR1838
carrying the elt-2::GFP transgene at the comma
stage or in early arrested embryos after control
(ctrl), lin-23, cul-1, gsk-3, or apr-1 RNAi or in
IA592 lin-23::FLAG-TY (see Materials and
Methods for genotype). Right, corresponding
Nomarski counterparts. Bar, 10 m. (B) lin-
23(RNAi) triggers predominantly hyperplasia
of the intestine under mild RNAi conditions.
Top, phenotypes of strain JR1838 carrying
elt-2::GFP (int.), JR667 wIs51 carrying a seam
cell GFP reporter (seam), and IA105 carrying
the hypodermal reporter dpy-7::GFP (hyp.) in
control or lin-23(RNAi) embryos at the three-
fold stage. Bar, 10 m. Bottom, quantification
of GFP-positive cells (mean SD, number of
embryos from two independent experiments
in parentheses): intestinal cells (int.): control,
20.0  1.0 (40); lin-23(RNAi), 32.7  6.8 (58);
seam cells: control, 19.4 1.2 (81) and lin-
23(RNAi), 18.3 2.8 (79); and hypodermal
cells (hyp.): control, 65.3 4.6 (42) and lin-
23(RNAi), 62.3  7.4 (45).
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die (Supplemental Table S1). We conclude that the lethal-
ity seen for strains homozygous for lin-23(e1883) and
ijIs18 is the result of inadequate maternal lin-23 function.
Those that survive grow to adulthood and are fertile. As
the lethality is fully complemented by the chromosomal
wild-type lin-23 allele, we conclude that the lin-23::
FLAG-TY (ijIs18) allele is only partially functional in the
developing embryo. Of significance, strains that are ho-
mozygous for lin-23(e1883) and ijIs18 also display embry-
onic intestinal hyperplasia (Figure 1A). This is slightly
less severe in cell number than the mean for lin-23(RNAi)
(Table 1, A and B), but in combination with cdc-25.1(ij48)
is indistinguishable from that of lin-23(RNAi) alone (Table
1, A and B). Therefore, lin-23::FLAG-TY (ijIs18) is only
partially functional with respect both to regulation of
cdc-25.1 and in supporting embryonic viability. It behaves
like a hypomorphic allele with respect to its maternal
function. As a control, we used pop-1(RNAi). In pop-1 mutants,
both the E blastomere and its sister cell MS adopt the intestinal
fate (Lin et al., 1998), thus generating additional intestinal cells
by an entirely different mechanism to cdc-25.1(ij48). In combi-
nation, pop-1(RNAi) and the cdc-25.1(ij48) mutation are, as ex-
pected, synergistic (Table 1A).
To test tissue specificity of the lin-23(RNAi) effect on em-
bryonic cell proliferation, we performed lin-23(RNAi) in the
C. elegans strains JR667 and IA105, which carry a seam cell
and hypodermal GFP markers, respectively. Under the con-
ditions that caused intestinal hyperplasia, no increased pro-
liferation of these other cell types was detected (Figure 1B
and Supplemental Table S1). We conclude that during em-
bryonic development in C. elegans, the intestinal cells are
particularly sensitive to the perturbation of LIN-23–medi-
ated regulation of CDC-25.1.
GSK-3 and APC Affect Intestinal Cell Number in a
CDC-25.1 S46-independent Manner
APC/Axin/GSK3 phosphorylation of the DSG motif of
human -catenin promotes its -TrCP–dependent degrada-
tion (Kikuchi et al., 2006), and mutations in APC or the
-catenin DSG motif are associated with human intestinal
hyperplasia. To test whether C. elegans members of this
complex regulate CDC-25.1 through S46, we performed
RNAi of candidate genes testing for synergy with the cdc-
25.1(ij48) mutation. As discussed above, in C. elegans the
Wnt pathway is required for the specification of the intesti-
nal fate, and similar to previous reports (Rocheleau et al.,
1997; Schlesinger et al., 1999), we observed that RNAi of
gsk-3 or apr-1, homologues of GSK3 and APC, respectively,
caused a complete lack of intestinal cells in 18% [gsk-
3(RNAi)] and 12% [apr-1(RNAi)] of embryos. However, we
found the majority of embryos to have more than the normal
20 intestinal cells (Figure 1A and Table 1A). To test whether
subsequent to their role in specification of the C. elegans
intestine, gsk-3 and apr-1 have a second function mediated
through CDC-25.1 S46 controlling the intestinal cell cycle,
we repeated the RNAi in the cdc-25.1(ij48) background (Ta-
ble 1). The number of intestinal cells increased significantly,
indicating that gsk-3 or apr-1 RNAi is synergistic with cdc-
25.1(ij48); and thus, like pop-1 (see above), do not function
through the same pathway as CDC-25.1 S46. Thus, both
gsk-3 and apr-1 RNAi knockdown can generate extra intes-
tinal cells in a manner distinct from that of cdc-25(ij48). We
tested the effect of simultaneous RNAi of apr-1 and gsk-3 and
found a complete lack of intestinal cells in 20% of embryos,
the same as for gsk-3(RNAi) alone; hence, no synergy was
observed. This is consistent with a model where apr-1 and
gsk-3 affect intestinal cell number in the same way.
Table 1. Quantification of intestinal cells through expression of elt-2::GFP reporter
A
RNAi Wild type cdc-25.1(ij48) p value -Fold increase % Hatch (wild type/ij48)
Control 25°C 20  1 (n  176/6) 24 4 (n  298/6) 0.001 1.2 98.8 0.498.4  1.5
Control 20°C 19.7  0.6 (n  22/1) 29.5  3.2 (n  60/1) 0.001 1.5 n.d.
pop-1 42  8 (n  175/3) 50 11 (n  152/3) 0.001 1.2 11
lin-23 37  8 (n  154/4) 36 7 (n  156/4) n.s. 1.0 73.2 10.869.8 13.2
cul-1 33  5 (n  129/2) 33 5 (n  134/2) n.s. 1.0 56.0 4.244.7  20.1
# gsk-3 28  6 (n  176/3) 35 9 (n  187/3) 0.001 1.3 27.2 5.420.8  10.2
# apr-1 27  5 (n  47/3) 35 6 (n  76/3) 0.001 1.3 n.d.a
B
lin-23(e1883)II cdc-25.1 (ij48)I p value -Fold increase
ijIs18 [lin-23::FLAG-TY] lin-23(e1883)II
ijIs18 [lin-23::FLAG-TY]
35  9 (n  62) 38  8 (n  69) 0.01 1.1
Data are expressed as mean SD. p value, two-tailed Student’s t test; n.s. p  0.05; in parentheses, n is number of embryos expressing
elt-2::GFP/number of independent RNAi experiments (for A). n.d., not determined. RNAi for control, pop-1, lin-23, cul-1, and gsk-3 RNAi were
by bacterial feeding and performed at 25°C. At this temperature, the cdc-25.1(ij48) allele shows a weaker phenotype than at 20°C and hence
fewer extraintestinal cells. # RNAi-produced embryos of three classes of phenotypes: loss of elt-2::GFP expression (see text), embryos
expressing elt-2::GFP in 20 cells, and embryos expressing elt-2::GFP in 20 cells (excess endoderm); only embryos with excess endoderm
phenotype were counted.
a RNAi was performed by microinjection, yielding to low sample size, embryos with excess endoderm phenotype usually arrest before the
threefold stage, loss of E fate was used as internal control for RNAi efficiency (17 and 16% for WT and IA530, respectively, in these
experiments).
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LIN-23 Regulates CDC-25.1 Abundance in the Embryo but
Not in the Germline
Our genetic data, and those of Hebeisen and Roy (2008), are
consistent with the proposal that the CDC-25.1(S46F) protein
escapes normal negative regulation by LIN-23. Previously,
we detected no difference in abundance between CDC-25.1
and CDC-25.1(S46F) in protein extracts from C. elegans
adults that contain embryos but where much of the CDC-
25.1 protein originates in the adult germline (Clucas et al.,
2002). We examined CDC-25.1 protein levels specifically in
embryonic extracts and detected a substantial increase in
CDC-25.1(S46F) abundance compared with the wild type
(Figure 2A). To investigate the potential role of LIN-23 in the
regulation of CDC-25.1 abundance in the C. elegans embryo,
we used lin-23 RNAi on both the wild-type strain and on the
cdc-25.1(ij48) mutant. lin-23(RNAi) resulted in a substantial
increase of wild-type CDC-25.1 to a level comparable with
that of the CDC-25.1(S46F) mutant but importantly did not
cause a further increase in mutant CDC-25.1(S46F) abun-
dance (Figure 2A). From this biochemical evidence, we con-
clude that LIN-23 negatively regulates CDC-25.1 abundance
in the C. elegans embryo and that the S46 residue is essential
for this normal pattern of regulation. In contrast, gsk-
3(RNAi) did not increase CDC-25.1 protein levels but in fact
resulted in a slight reduction of both CDC-25.1 and CDC-
25.1(S46F), whereas the relative elevated abundance of
CDC-25.1(S46F) compared with CDC-25.1 remained. Thus,
we conclude that GSK-3 is not involved in destabilizing
CDC-25.1 via S46 (Figure 2B). The reason for the observed
reduction of both CDC-25.1 and CDC-25.1(S46F) abundance
with gsk-3(RNAi) is unclear, but CDC-25.1 rapidly declines
in abundance during early embryogenesis and is not detect-
able by immunofluorescence by 3 h after fertilization. gsk-
3(RNAi) does cause the accumulation of significant numbers
of old dying embryos that never hatch, and it is inevitable
that the ratio of older-to-younger embryos is altered. This
might account for the difference.
The intestinal specific hyperplasia of cdc-25.1(ij48) mu-
tants prompted us to test whether CDC-25.1(S46F) protein
levels were elevated exclusively in embryonic intestinal
cells, although this seemed unlikely due to the substantial
difference in abundance observed by Western blots from
protein extracts of intact embryos where all tissues are
present. As found previously by immunostaining, the abun-
dance of maternally supplied CDC-25.1 in the C. elegans em-
bryo rapidly declines during the first few cleavages (Ashcroft et
al., 1999; Clucas et al., 2002; Kostic and Roy, 2002) and with
the conditions used here becomes undetectable between the
100- and 200-cell stage. Immunostaining revealed an ap-
proximately twofold increase of CDC-25.1(S46F) abundance
compared with CDC-25.1 during the 10- to 60-cell stage of
embryogenesis in probably all cells (Figure 2C, Table 2,
Supplemental Figure S1, and Supplemental Table S2). De-
tails of how we quantified CDC-25.1 immunofluorescence
are given in the legend to Supplemental Figure S1.
lin-23(RNAi) increased wild-type CDC-25.1 abundance in
all blast cells during the 10- to 60-cell stage in a manner that
is indistinguishable from the CDC-25.1(S46F) mutant but
did not further increase CDC-25.1(S46F) abundance. Simi-
larly, RNAi of cul-1 caused an increase in CDC-25.1 but not
CDC-25.1(S46F) protein levels. In contrast, gsk-3(RNAi) had
no effect (Figure 2D, Table 2, Supplemental Figure S1, and
Supplemental Table S2). Thus, we conclude that in the
wild type, LIN-23 promotes the degradation of CDC-25.1
in all cells of the early C. elegans embryo and conversely
the CDC-25.1(S46F) mutant is stabilized in all cells of the
early embryo.
The evidence presented above suggesting LIN-23–depen-
dent destabilization of CDC-25.1 that is dependent on the
presence of S46 caused us to test whether these proteins exist
within a complex. We found in embryonic extracts that
LIN-23 coimmunoprecipitated with CDC-25.1 (Figure 3) and
that relatively more LIN-23 coimmunoprecipitated with
wild-type CDC-25.1 than with mutant CDC-25.1(S46F), al-
though CDC-25.1 itself is significantly less abundant than
the mutant (Figure 3A). Immunoprecipitated CDC-25.1 was
probed with an anti-ubiquitin antibody and a high-molecu-
lar-weight smear was detected; this material was not de-
tected in the IgG immunoprecipitation controls, suggesting
that it is bound specifically by the anti-CDC-25.1 antibody
(Figure 3A). Like LIN-23, this material is less abundant for
CDC-25.1(S46F) (Figure 3A), where reciprocally the nonu-
biquitinated CDC-25.1(S46F) species is more abundant.
These data are consistent with a model where LIN-23 targets
CDC-25.1 for ubiquitin-mediated proteolysis in the develop-
ing embryo, and with CDC-25.1 S46 being important for that
regulation. However, with our current biochemical data this
Figure 2. RNAi of lin-23 and cul-1 but not gsk-3 mimic CDC-
25.1(S46F) protein increase in all embryonic blast cells. (A) Extracts
derived from JR1838 (WT, lanes 1 and 2) or IA530 cdc-25.1(ij48)
(S46F, lanes 3 and 4) embryos after control (	) or lin-23(RNAi) ()
were applied to SDS-PAGE followed by Western blotting against
CDC-25.1, LIN-23, or -actin as loading control. (B) Essentially as in
A, but RNAi was performed against gsk-3 followed by Western
blotting against CDC-25.1, GSK3, and -actin. (C) Indirect immu-
nostaining of CDC-25.1 (red panels) with corresponding DAPI
counterparts (blue panels) in JR1838 (WT) or IA530 cdc-25.1(ij48)
(S46F) at approximately the 4, 30, 60, or 200 cell stage. Bar, 10 m.
The images shown are representative. Images like these were used
in the quantification of intensity of CDC-25.1 immunofluorescence;
details of how this was performed are given in the legend to
Supplemental Figure 1. (D) Indirect immunostaining of CDC-25.1
(red panels) with corresponding DAPI images (blue channels) in
JR1838 (WT) or IA530 cdc-25.1(ij48) (S46F) after control, lin-23, cul-1,
or gsk-3 RNAi. Bars, 10 m.
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model is speculative. The C. elegans embryo is impermeable
to most drugs; hence, we are unable to block proteasomal
degradation to test whether the putative polyubiquinated
CDC-25.1 species further accumulates. Likewise, we are un-
able to block ubiquitination in a manner that would permit
biochemical analysis.
CDC-25.1 within the developing embryo is supplied ma-
ternally and also is abundant in the maternal germline (Fig-
ure 4I) but not in other postembryonic tissues (Ashcroft and
Golden, 2002; Clucas et al., 2002). By comparing the abun-
dance of CDC-25.1 in embryonic extracts with extracts from
late L4 larvae (where the only source of CDC-25.1 is the
developing germline), we determined that the S46F muta-
tion does not detectably affect CDC-25.1 abundance in the
germline of such animals (Figure 3B). Also, the interaction
between LIN-23 and CDC-25.1 is either absent or much
reduced in the germline, because LIN-23 did not coimmu-
noprecipitate efficiently with germline-derived CDC-25.1
(Figure 3C).
However, as detected by immunofluorescence the LIN-23
protein is present both in all blast cells of embryos (Figure 4,
A–D) and in the wild-type germline (Figure 4, F,G, H, and J).
We find that LIN-23 is present in the germline from the tip
of the distal arm to the maturing oocytes (Figure 4F). Its
abundance seems relatively similar between the distal and
proximal zones; however, its localization is concentrated
within cytosol and is relatively excluded from nuclei (Figure
4, F–H and J). The distal region of the gonad is a syncytial
tube with the germline nuclei packed around the outside
with a hollow core. We find that LIN-23 is concentrated
Table 2. Comparative analysis of CDC-25.1 protein levels in the early embryo
Embryos (JR1838) WT-fold increase p value
Embryos (IA530
cdc-25.1 ij48) ij48-fold increase p value
10–20n 22 (3) 22 (3) 1.4 0.001
30–40n 25 (2) 16 (2) 2.2 0.001
50–60n 24 (3) 24 (3) 1.9 0.001
100–200n 19 (3) 19 (3) 1.4 n.s.
lin-23 RNAi 10–20n 15/18 (2) 1.7 0.001 15/16 (2) 1.1 n.s.
30–40n 19/18 (2) 2.8 0.001 16/9 (2) 1.0 n.s.
50–60n 13/15 (2) 2.3 0.001 14/16 (2) 1.0 n.s.
100–200n 10/13 (2) 1.6 0.01 13/13 (2) 1.0 n.s.
cul-1 RNAi 30–40n 46/39 (3) 2.2 0.001 40/33 (3) 1.1 n.s.
gsk-3 RNAi 30–40n 56/35 (3) 0.9 n.s. 56/42 (4) 1.1 n.s.
Average -fold increase of CDC-25.1 levels as estimated by immunostaining in embryos of wild-type strain JR1838 compared with IA530
cdc-25.1(ij48) (compare WT -fold increase with ij48-fold increase). Embryos: number of embryos (number of independent experiments); in
RNAi experiments: control RNAi/gene-specific RNAi. p value, two-tailed Student’s t test, -fold increase was determined as described in
Supplemental Table 2. See Supplemental Figure 1 for examples on original data sets and a detailed explanation of how quantification was
performed.
Figure 3. CDC-25.1(S46) is crucial for LIN-23
interaction in C. elegans embryos. (A) Immu-
noprecipitation of CDC-25.1 from C. elegans
wild-type strain JR1838 (WT, lanes 1, 3, and 4)
compared with IA530 cdc-25.1(ij48) (S46F,
lanes 2, 5, and 6). Samples were precipitated
with an anti-CDC-25.1 antibody (lanes 3 and
5) and as control rabbit IgG (lanes 4 and 6).
Three percent (9 g of total protein) of the
total fraction were applied to SDS-PAGE for
input (lanes 1 and 2) and 30% of the eluates
(lanes 3–6), followed by Western blotting and
sequential probing with anti-ubiquitin, anti-
LIN-23, and anti-CDC-25.1 antibodies. Small
inset, weak exposure of input for anti-LIN-23
to show equal protein loading. A typical result
obtained from two independent experiments
is shown. (B) Comparison of CDC-25.1 protein
levels from L4-stage hermaphrodites, mainly
expressing CDC-25.1 in the germline (lanes 1
and 2), with the protein levels in the embryo
(lanes 3 and 4). Similar amounts of total pro-
teins derived from extracts of JR1838 (WT) and IA530 cdc-25.1(ij48) (S46F) were applied to SDS-PAGE, followed by Western blotting with
anti-CDC-25.1 and anti--ACTIN antibodies, result was obtained from two independent experiments. (C) Immunoprecipitation of CDC-25.1
with the anti-CDC-25.1 antibody (lanes 1 and 3) or as control rabbit IgG (lanes 2 and 4) from extracts derived from L4-stage hermaphrodites
(lanes 1 and 2) or embryos (lanes 3 and 4). Eluates were applied to SDS-PAGE followed by Western blotting against LIN-23 and CDC-25.1
(similar to A, two independent experiments). (D) Immunoprecipitation of LAP-tagged CDC-25.1 from embryos. Embryos containing
transgenically expressed CDC-25.1::LAP (strain IA535) or as a control GFP::LacZ (strain JR 1838) expressed in intestinal cells were
immunoprecipitated with anti S-tag resin. We loaded 1.25% of the total fraction on SDS-PAGE for the input and flow-through (lanes 1–4) and
33% of the total for the eluates (5–6). Western blots were probed with anti-GFP antibodies (top) or anti-LIN-23 antibodies (bottom).
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throughout the core and in the cytosolic spaces between the
nuclei and is either absent from, or present at a much re-
duced level, in the nuclei themselves (Figure 4, G, H, and J).
Within developing oocytes in the proximal region of the
gonad, it is also more abundant in the cytoplasm than nuclei
(Figure 4F).
CDC-25.1 in the germline shows a very obvious gradi-
ent of abundance (Figure 4I) being at very low levels in
the distal region, becoming obvious in young developing
oocytes (toward the top left of the gonad shown) and
increasing significantly in more mature oocytes (those
toward the top right of the gonad shown). Also, although
CDC-25.1 is abundant within the cytoplasm of the oo-
cytes, it is slightly more concentrated within their nuclei
(Figure 4I). CDC-25.1 is much less abundant within the
distal arm of the gonad (Figure 4I), but extended expo-
sures at high magnification suggest that it is present being
located both outside and within the nuclei, but absent
from the periphery of nuclei (Figure 4K). By contrast,
LIN-23 seems to be absent from these nuclei (Figure 4J).
These data demonstrate the progressive accumulation of
CDC-25.1 in maturing oocytes and this occurs in the pres-
ence of LIN-23.
An interesting observation was the differential localiza-
tion of LIN-23 in the cells of the early embryo. It is generally
distributed throughout the cytosol, but its localization is
dynamic being differentially excluded from the nucleus for
much of the cell cycle, but a fraction of it accumulates to the
nuclear compartment late in the cycle shortly before cell
division (Figure 4, A–D). In the embryos shown, the nuclear
compartment accumulation of LIN-23 is seen in a late AB
blastomere (Figure 4B) but is absent in a slightly younger AB
blastomere (Figure 4A). Similarly, it can be seen in both the
ABa and ABp blastomeres but absent from the nuclei of the
EMS and P2 blastomeres (Figure 4C). Because the ABa and
ABp blastomeres divide slightly earlier than EMS and P2,
they are inevitably later in the cell cycle. However, this
pattern is not lineage dependent. In other embryos, we have
observed localization to a nuclear compartment in EMS and
P2 also. Reminiscent of the behavior of LIN-23 at the two-cell
stage, the CDC-25.1 protein has previously been shown to
accumulate in the nuclear compartment slightly quicker in
the AB blastomere than in P2, and this is dependent on the
function of the PAR proteins (Rivers et al., 2008). However,
once localized to the nuclear compartment by the late two-
cell stage, CDC-25.1 then remains predominantly nuclear
throughout most of the cell cycle during the subsequent
embryonic stages (Figure 2C; Clucas et al., 2002). This con-
trasts with what is likely to be a more dynamic behavior of
LIN-23 which in fixed, stained specimens is more frequently
absent from nuclei than CDC-25.1 during later developmen-
tal stages (Figure 2, C and D). The dynamic behavior of
LIN-23 around the chromatin in early embryonic blas-
tomeres requires further investigation, however, is not ob-
served in the adult germline where it is relatively excluded
from the nuclear compartment at all stages (Figure 4, F–H
and J).
We were interested to determine whether maternally sup-
plied LIN-23 regulates CDC-25.1 in the embryo. Homozy-
gotes of the null allele lin-23(e1883) develop into sterile
adults with postembryonic intestinal nuclear division de-
fects as observed previously (Kipreos et al., 2000); lin-
Figure 4. Subcellular distribution of LIN-23
in early embryonic blastomeres and of LIN-23
and CDC-25.1 in adult germline. (A–E) Indi-
rect immunostaining of LIN-23 in wild type
(A–D) or lin-23(RNAi)–treated embryos (E) by
using an anti-LIN-23 antibody (red panels)
with corresponding DAPI counterparts (blue
panels). Early two-cell embryo (A), late two-
cell embryo (B), four-cell embryo (C and E),
and 28-cell embryo (D). Nuclear localization of
LIN-23 indicated by white arrows in the blas-
tomere AB (B) and ABa and Abp (C). Bar, 10
m. (F) Indirect immunostaining of LIN-23 in
the adult germline of the wild-type strain N2
(green panels) with corresponding DAPI
counterparts (blue panels). The position of oo-
cyte nuclei are marked with white arrows and
the turn of the gonad labeled with T. The
proximal and distal arms of the gonad are
labeled and both shown are from the same
intact isolated gonad. Bar, 10 m. (G–H) Indi-
rect immunostaining of LIN-23 in the adult
germline of the wild-type strain N2 (green
panels) with corresponding DAPI counter-
parts (blue panels). The section shown is from
approximately the middle of the distal arm.
The nuclei are packed around the outside of
the distal arm, as seen in the top focal plane
(G). The core of the distal arm does not contain
nuclei, but has strong LIN-23 staining (H). Bar,
10 m. (I) Indirect immunostaining of CDC-
25.1 in the adult germline of the wild-type strain N2 (green panels) with corresponding DAPI counterparts (blue panels). The position of
oocyte nuclei are marked with white arrows and the turn of the gonad labeled with T. The proximal and distal arms of the gonad are labeled
and are shown in the same orientation as that for F. Bar, 10 m. (J) Indirect immunostaining of LIN-23 in the adult germline of the wild-type
strain N2 (green panels) with corresponding DAPI counterparts (blue panels). The section shown is from approximately the middle of the
distal arm similar to the section shown in G, but at higher magnification. Bar, 10 m. (K) Indirect immunostaining of CDC-25.1 in the adult
germline of the wild-type strain N2 (green panels) with corresponding DAPI counterparts (blue panels). The section shown is from
approximately the middle of the distal arm similar to the section shown in G, but at higher magnification. Bar, 10 m.
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23(e1883)/ heterozygotes are phenotypically wild type
(Figure 5A). We determined that the heterozygotes have
50% of the wild-type LIN-23 abundance (Figure 5B); there-
fore, 50% of normal LIN-23 protein abundance is sufficient
for viability and to prevent embryonic intestinal hyperplasia
by dysregulation of CDC-25.1. The intestinal cell number
was normal in all embryos derived from a heterozygous
mother, regardless of their zygotic genotype; therefore, ma-
ternal LIN-23 function is sufficient to regulate maternal
CDC-25.1 in embryos and to control intestinal cell number
during embryonic development. We conclude that the neg-
ative regulation of maternally derived CDC-25.1 by mater-
nally derived LIN-23 is developmentally regulated being
activated after fertilization in the developing embryo. This is
concurrent with the onset of a spatially dynamic behavior of
LIN-23 where it periodically accumulates to the nuclear
compartment late in the cycle shortly before cell division.
Distinct Functions for LIN-23 in the C. elegans Embryo
and Germline
Our investigations detailed above indicate that maternally
supplied LIN-23 negatively regulates CDC-25.1 abun-
dance in the embryo but not in the developing germline
where both proteins are also present. Here, we find genetic
evidence for differences in LIN-23 function between the germ-
line and embryo. We generated a lin-23::FLAG-TY epitope-
tagged transgene and observed that a chromosomally inte-
grated version of this lin-23::FLAG-TY (ijIs18), was only
partially functional. In strains where the only lin-23 function is
provided from lin-23::FLAG-TY (ijIs18), the sterility defect of
the lin-23(e1833) null mutant is completely rescued (Figure 6A).
However, embryos derived from such adults displayed a high
frequency (75%) of embryonic lethality (Figure 6B). There-
fore, although lin-23::FLAG-TY (ijIs18) completely comple-
ments the germline defect of the lin-23(e1833) null, it only
partially complements its embryonic functions. Also, the viable
embryos (and some of the nonviable) displayed an embryonic
intestinal hyperplasia (Figure 1A), which we hypothesized
might be by a partial failure of S46-mediated regulation of
CDC-25.1. Because the cdc-25.1(ij48) mutant does not cause
embryonic lethality, the lethality associated with the partially
functional lin-23::FLAG-TY (ijIs18), must be caused by another
mechanism.
To test whether lin-23::FLAG-TY (ijIs18) was defective in
the regulation of CDC-25.1, we assessed the CDC-25.1 pro-
tein levels. CDC-25.1 abundance was elevated in the
lin-23::FLAG-TY strain to a level similar to that of the mutant
CDC-25.1(S46F) in a wild-type lin-23 background, whereas
the abundance of CDC-25.1(S46F) was not altered (Figure
6C). Therefore, the increase in embryonic CDC-25.1 abun-
dance caused by lin-23::FLAG-TY (ijIs18) is S46 dependent.
We then tested the physical association of LIN-23::FLAG-
TY and CDC-25.1. We found substantially less LIN-23::
FLAG-TY than wild-type LIN-23 coimmunoprecipitated
with wild-type CDC-25.1 (Figure 6D), although the abun-
dance of CDC-25.1 was elevated and LIN-23::FLAG-TY was
similar to endogenous LIN-23 levels. We conclude that the
deregulation of CDC-25.1 by lin-23::FLAG-TY is via S46 and
that the epitope-tagged version of the LIN-23 protein may be
less effective at forming a complex with CDC-25.1.
lin-23(RNAi) Causes Hyperplasia of the E Lineage and
Fate Transformation in the C Lineage
The developmental fate switch that occurs at the birth of the
two sister-cells MS (mesoderm) and E (endoderm) is associated
with a concurrent change in the control of the cell cycle in the
cell lineages derived from these two blastomeres. The cell
cycles of the E cell lineage are notably longer from the point
of the birth of the two daughters of E, Ea and Ep (the 2 E-cell
stage), compared with the equivalent MS cell lineage (Figure
7A). The switch to the longer cell cycle in the E lineage is
thought to be the result of the introduction of a Gap phase in
G2 in the intestinal lineage from Ea and Ep (Edgar and
McGhee, 1988). Also, to generate precisely 20 intestinal cells
from E, the cell cycle terminates in 12 of the cells present at
the 16 E cell stage and a fifth cleavage occurs in only four of
the 16 E cells (Figure 7A; Sulston et al., 1983). By contrast, all
of the MS cells undergo a fifth cleavage.
To investigate cell lineage defects caused by lin-23(RNAi),
we used four-dimensional microscopic lineage analyses. We
used the intestinal marker elt-2::GFP to facilitate the identi-
fication of cells of the intestinal fate. lin-23(RNAi) caused a
significant shortening of the endodermal cell cycles from the
4 E cell stage. In the wild type, the times from the second to
third, third to fourth, and the fourth to fifth cleavages (from
the E blastomere) are 45, 65, and 130 min, respectively.
With lin-23 RNAi, these are typically shortened to 35, 55,
and 70 min, respectively (Figure 7B), plus lin-23 RNAi also
caused deregulation of cell cycle exit after the fourth cleav-
age; most intestinal cells undergo prematurely a fifth cleav-
Figure 5. Maternally supplied LIN-23 controls intestinal cell pro-
liferation in the embryo. (A) Offspring derived from C. elegans strain
IA565 carrying the intestinal-specific GFP marker npa-1::GFP::LacZ
(see Materials and Methods for genotype) was analyzed for the num-
bers of intestinal nuclei in lin-23(e1883) null [lin-23(	/	)], lin-
23(e1883) heterozygotes [lin-23(/	)], or lin-23 wild type [lin-23
(/)] hermaphrodites. We were able to confirm the genotype of
larvae and embryos using PCR and a restriction site polymorphism
between the mutant and wild type. (B) Western blot analysis of
LIN-23 protein levels of whole animal lysates of strains analyzed in
the top panels. C, cross-reacting band detected with the anti-LIN-23
antibody. A typical result is shown from two independent experi-
ments and several comparative protein loadings.
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age (Figure 7B); and in some embryos, we observed a few
cells undergo a sixth cleavage (data not shown). Thus, in the
E lineage, both the cell cycle length and the decision to exit
the cell cycle at the 16 E cell stage are affected by lin-23
RNAi. The variability of the cell lineage defects seen with
lin-23 RNAi might relate to variation in the extent of inter-
ference in different embryos. This interpretation is consistent
with the spectrum of outcomes observed, from apparently
wild type, through viable with intestinal hyperplasia, to
embryonic lethality and the C lineage transformation dis-
cussed below. The effects within the E lineage are strikingly
similar to those of the cdc-25.1(ij48) mutant (Figure 7C;
Clucas et al., 2002) and to the combination of lin-23(RNAi)
plus the cdc-25.1(ij48) mutant (Figure 7D). In the lineage
shown for lin-23(RNAi) plus cdc-25.1(ij48), a slightly more
severe shortening of the E lineage cell cycles is observed,
compared with the cdc-25.1(ij48) mutant alone (Figure 7C).
Because there is some variability in the E lineage defects for
different embryos of both cdc-25.1(ij48) mutants and lin-
23(RNAi), it is impossible to say whether this apparently
minor additive effect is informative or not. In principle, we
cannot rule out whether CDC-25.1(S46F) is slightly destabi-
lized by LIN-23 or whether LIN-23 regulates another mole-
cule that has a minor additional effect on the rate of the E
lineage cell cycles. It is however possible that this is just an
extreme end of the spectra for both lin-23(RNAi) and the
cdc-25.1(ij48) mutant. By contrast, lin-23(RNAi) did not cause
a shortening of the cell cycles in the MS lineage; and indeed,
in the embryo shown there was a slight lengthening of some
of the cell cycles from the MSp cell (Figure 7B). This is
consistent with lin-23 and cdc-25.1 functioning in the same
pathway controlling these two aspects of the intestinal lin-
eage; its long cell cycle and the decision to exit the cell cycle
after the fourth cleavage and thus determining the cell num-
ber of this organ.
We found an additional cell lineage defect in embryos
severely affected by lin-23(RNAi), a cell fate transformation
in the C lineage where the descendants of Cp (the posterior
daughter of C) ectopically adopt the intestinal fate as deter-
mined by lineage and expression of the terminal intestinal
fate marker elt-2::GFP (Figure 7I). In addition, these cells
were observed to form a cluster reminiscent of the cell
migrations involved in intestinal organogenesis and hence
behaved like intestinal cells. Like the intestinal cells derived
from the E blastomere with lin-23(RNAi) and in the cdc-
25.1(ij48) mutant, these ectopically derived C lineage intes-
tinal-fate cells display a shorter cell cycle than the wild-type
E lineage, and this is not enhanced in the cdc-25.1(ij48)
background (Figure 7J).
Cell Fate Transformations by gsk-3(RNAi) Demonstrate
the Association of Commitment to Intestinal Fate, the
Onset of the Long Intestinal Cell Cycles, and Cell Cycle
Length Sensitivity to Perturbation of CDC25.1 Regulation
GSK3 affects endodermal fate specification in opposite ways
in the E and C lineages such that gsk-3(RNAi) causes a
transformation within the E lineage to a mesodermal fate
and of the Cp lineage to the intestinal fate (Schlesinger et al.,
1999; Maduro et al., 2001). We used these fate transforma-
tions to further investigate the relationship between intesti-
nal fate specification, the developmental switch to the longer
cell cycle in intestinal cells, and sensitivity of the C. elegans
embryonic cell cycles to dysregulation of LIN-23–dependent
regulation of CDC-25.1. As stated above, we used the intes-
tinal marker elt-2::GFP to facilitate the identification of cells
of the intestinal fate. We define the cell in which commit-
ment to the intestinal fate occurs as the single progenitor cell
of a lineage of cells that all go on to express this marker.
Thus, in wild type C. elegans, this commitment occurs in the
E blastomere where expression of the elt-2::GFP marker is first
seen two cell divisions later in the 4 granddaughters of E.
Here within the E lineage, gsk-3(RNAi) caused a delay in
the commitment to and subsequent specification of the in-
testinal fate. In four of six embryos analyzed, gsk-3(RNAi)
caused the anterior daughter of E (Ea) to generate nonintes-
tinal cells and the posterior daughter of E (Ep) to produce
Figure 6. The lin-23::FLAG-TY allele rescues
germline function of a lin-23 null mutant but
causes embryonic defects. (A) Relative per-
centage of viable F1 embryos produced by the
C. elegans strains N2 Bristol (WT), IA589 lin-
23(e1883) null mutant carrying the lin-23::
FLAG-TY allele (lin-23::FLAG-TY), and the lin-
23(e1883) null mutant (derived from CB3514).
For strain genotypes, see Materials and Meth-
ods. Mean SD, 100 10.4% (WT, three inde-
pendent experiments), 129 16.3% (lin-23::
FLAG-TY), and 0% (no viable embryos) [lin-
23(e1883)], six independent experiments for
both. (B) Percentage of hatch rate of N2 Bristol
(WT) and IA589 (lin-23::FLAG-TY). Mean SD
(number of embryos in parentheses): 100
2.5% (525) (WT, three experiments), 28.7
15% (1350) (lin-23::FLAG-TY, six experiments).
(C) Comparison of CDC-25.1 stability in lin-23
and lin-23::FLAG-TY embryos. Equal amount
of total protein from embryonic extracts of
JR1838 (WT, LIN-23, lane 1), IA530 cdc-
25.1(ij48) (S46F, LIN-23, lane 2), IA592 (WT, LIN-23::FLAG-TY, lane 3), and IA593 (S46F, LIN-23::FLAG-TY, lane 4) were applied on
SDS-polyacrylamide gel and blotted against CDC-25.1, LIN-23, and -actin. The cause for the low LIN-23::FLAG-TY level in the CDC-
25.1(S46F) background is currently unknown. (D) Immunoprecipitation of CDC-25.1 (lanes 3 and 5) compared with control IgG (lanes 4 and
6) from embryonic extracts derived of the strains JR1838 (WT, lanes 1, 3, and 4) or IA592 (TAG, lanes 2, 5, and 6) a lin-23 null strain carrying
the lin-23::FLAG-TY allele (see Materials and Methods). Specific copurification of endogenous LIN-23 is observed to endogenous CDC-25.1 but
LIN-23::FLAG-TY results in weaker binding to CDC-25.1 (compare lanes 5 and 3). Samples were precipitated with the CDC-25.1 antibody and
3 and 30% of the total fraction applied to SDS-PAGE for input (lanes 1 and 2) and eluates (lanes 3–6), respectively, followed by Western
blotting against LIN-23 or CDC-25.1. The presence of the tag in LIN-23 promotes an up-shift of 2.4 kDa in SDS-PAGE.
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intestine (two embryos shown, Figure 7, E and F); thus,
commitment to the intestinal fate is delayed by one cell cycle
occurring in the daughter-cell of E, Ep. In one embryo, the
intestinal fate commitment was delayed by an additional cell
cycle and occurred in Epr (Figure 7G); in one embryo, the E
lineage was as wild type (data not shown). In the wild-type
E lineage, the switch to the long intestinal cell cycle occurs
one division after commitment, the cells Ea and Ep being the
first to have a long cell cycle (Figure 7A). Where gsk-3(RNAi)
delayed commitment to the intestinal fate by one cell cycle
occurring in Ep, the switch to the longer intestinal cell cycle
was equivalently delayed such that it occurred in Epl and
Epr (Figure 7, E and F). Similarly, where commitment oc-
curred two cell cycles late in Epr, the first longer cell cycle
was of its daughters Epra and Eprl (Figure 7G). Conversely,
those components of the E lineage that with gsk-3(RNAi) fail
to commit to the intestinal fate (do not give rise to elt-2::GFP
expression), derived from Ea or from Epl (Figure 7, E and G)
display a short cell cycle of very similar length to that of a
normal MS lineage (Figure 7A). We examined the sensitivity
of gsk-3(RNAi) altered E-lineages to the perturbation of LIN-
23–dependent regulation of CDC-25.1. When gsk-3(RNAi)
caused commitment to occur one cell cycle late in Ep in the
cdc-25.1(ij48) mutant background, the intestinal cell cycles
from Epl and Epr onward were shortened compared with
the equivalent gsk-3(RNAi) in the wild-type background
(Figure 7, E and F). However, the short MS-like cell cycles
from Eal and Ear are of similar lengths in the wild type and
cdc-25.1(ij48) backgrounds (Figure 7, E and F) and hence are
not sensitive to perturbation of LIN-23–dependent regula-
tion of CDC-25.1.
Similarly, the transformation in cell fate within the C
lineage caused by gsk-3(RNAi) suggests a stringent associa-
tion between intestinal-fate specification and sensitivity to
CDC-25.1 dysreguation. Here, gsk-3(RNAi) promoted ec-
topic intestinal-fate specification in a proportion of the C
lineage with commitment to the intestinal fate occurring in
Cp (Figure 7, K and L), the same point as seen above with
lin-23(RNAi) (Figure 7, I and J). In a wild-type background,
this gsk-3(RNAi) transformation caused a switch to a typical
long intestinal cell cycle one division later in the daughters
of Cp (Figure 7K). When performed in the cdc-25.1(ij48)
mutant background, these intestinal-like cell cycles were
shortened (Figure 7L). The combined effect of the cdc-
25.1(ij48) mutant plus gsk-3(RNAi) generates in the lineage
from Cp, intestinal-fate cells that have cell cycle lengths
Figure 7. Cell lineage analysis of the E, MS, and C blastomeres. Lineages are derived from wild type or cdc-25(ij48) embryos with or without
lin-23 or gsk-3(RNAi), as indicated. The wild-type C blastomere generates ectodermal and mesodermal cells; only Cp is shown. Lineages
expressing the intestinal marker elt-2::GFP are depicted in green; wild-type MS lineage is in red; wild-type C is in pink; and undetermined
but nonintestinal fates in blue. Vertical lines, time between cell divisions; time, minutes post first cleavage. Lineages were followed up to the
time indicated by the ends of vertical lines. Lineage analysis was performed on the following: three embryos each for lin-23 or gsk-3 RNAi
in the wild-type background and gsk-3(RNAi) in the cdc-25.1(ij48) background and two embryos for lin-23(RNAi) in the cdc-25.1(ij48)
background. For the effect of lin-23(RNAi) on the E lineage, those shown are typical, but there is some variability with RNAi. For gsk-3(RNAi)
on the E lineage, in four embryos analyzed the lineage derived from Ep adopted the intestinal fate, in one embryo the lineage derived from
Epr adopted the intestinal fate, and in one embryo the E lineage was wild type. For gsk-3(RNAi) on the C lineage, all six embryos analyzed
behaved as shown with Cp adopting the intestinal fate. For lin-23(RNAi) on the C lineage, ectopic intestinal fate from Cp was observed in
two embryos (one of each genotype) and three were wild type. In all cases, the point of specification of the endodermal fate was determined
by tracing back to a common ancestor, those cells that at the end of the lineage recordings are determined to express the elt-2::GFP marker.
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equivalent to the same cells transformed to the intestinal fate
by lin-23(RNAi) (Figure 7, H and L).
Additional Observations on gsk-3(RNAi) Cell Fate
Transformations in the E and C Lineages
We made some additional observations about the fate trans-
formations caused by gsk-3(RNAi). Here, ectopic intestinal
fate from Cp was observed in six of six gsk-3(RNAi) embryos
analyzed (two are shown; Figure 7, K and L), but not in Ca,
the anterior daughter of C. Previously, it has been argued C
might adopt an EMS-like fate rather than E-like with gsk-
3(RNAi) (Maduro et al., 2001), and our data support that
model. The gsk-3(RNAi) fate specification defect in the C
lineage seems to display polarity. Only the posterior cell
touches the embryonic posterior polarity center (blastomere
P2 and descendants) (Schierenberg, 1987; Goldstein, 1995;
Thorpe et al., 2000; Bischoff and Schnabel, 2006), required to
specify the posterior identity (Kaletta et al., 1997), which in
this case is intestinal identity. Also, in those cases with
gsk-3(RNAi) where we observed a delay within the E lineage
to the commitment to the intestinal fate, occurring in either
Ep or Epr, in all cases observed the E-lineage cell where
intestinal commitment occurred and its parental cell, were in
physical contact with the Wnt-signaling cell P2, or a descen-
dant of P2. Hence, the observed polarity of specification may
be the result of Wnt signaling. Thus, intestinal fate specifi-
cation within both the E and C lineages, with gsk-3(RNAi),
may be responding to a posterior signal.
In summary, from our cell lineage analysis we propose
that gsk-3(RNAi) causes a delay in the specification of the
intestinal fate within the E-lineage as assessed both by ex-
pression of the intestinal-specific marker elt-2::GFP and the
switch to the long intestinal cell cycle. The longer Gap
phase-containing intestinal cell cycles are sensitive to CDC-
25.1 activity such that the cell cycles are shortened by the
stabilization of CDC-25.1 by perturbation of its LIN-23-de-
pendent regulated degradation. This sensitivity to elevated
CDC-25.1 function may be specific to Gap phase containing
C. elegans embryonic cell cycles because it is not seen in the
MS lineage whose cell cycles are short and without an
observable Gap phase.
DISCUSSION
In cultured mammalian cells, cell cycle phase-specific fluc-
tuations in the abundance of Cdc25s caused by checkpoint-
specific -TrCP–dependent degradation serve to control cell
cycle progression. Here, we demonstrate in the C. elegans
embryo that LIN-23, the C. elegans orthologue of -TrCP,
promotes a gradual decline in the abundance of maternally
supplied CDC-25.1 in probably all cells and spanning sev-
eral embryonic cell cycles, rather than the cyclic pattern for
cultured vertebrate cells. Ultimately, this mechanism con-
trols the number of cells in one C. elegans organ, the intestine.
Because the -TrCP–dependent degradation of human
CDC25A and B occurs via DSG and DDG motifs, respec-
tively (Busino et al., 2003; Jin et al., 2003), and the CDC-
25.1(S46F) mutant that is resistant to LIN-23–dependent
degradation is within a DSG motif, we speculate that the
molecular mechanism may be conserved between humans
and C. elegans.
We demonstrated previously by genetic means that cdc-
25.1 function within the embryo is maternal in origin (Clucas
et al., 2002). Consistent with this, here we demonstrate the
presence of the CDC-25.1 protein in the developing C. elegans
germline, and its progressive accumulation during oocyte mat-
uration. We also demonstrate that the lin-23 function that
promotes the normal degradation of CDC-25.1 in the em-
bryo is maternal in origin and show that the LIN-23 protein
is present throughout the adult C. elegans germline. There-
fore, at the time of fertilization C. elegans oocytes contain
maternally derived LIN-23 and CDC-25.1 protein synthe-
sized in the germline. During the first few embryonic cell
divisions, the CDC-25.1 protein rapidly declines in abun-
dance and becomes undetectable by immunofluorescence
between the 100- to 200-cell stage (Clucas et al., 2002).
We find several lines of evidence that the relationship
between CDC-25.1 and LIN-23 changes between the germ-
line environment and the embryonic environment. The
CDC-25.1(S46F) mutant confers stability in the early embryo
by escaping LIN-23–dependent degradation causing the
mutant protein to be more abundant than the wild type;
however, we detected no difference in abundance in protein
from the germline. Within the germline, the CDC-25.1 pro-
tein accumulates in the presence of LIN-23, being most
abundant in the most mature oocytes. This contrasts with
the rapid degradation of CDC-25.1 in the embryo. Although
we were able to coimmunoprecipitate LIN-23 and CDC-25.1
relatively efficiently from embryonic protein extracts, at best
only a trace of LIN-23 was detected by the same method
from germline-derived material. The genetic behavior of the
epitope-tagged transgene lin-23::FLAG-TY (ijIs18) is also per-
tinent. It rescues completely the germline defect of the lin-
23(e1833) null mutant by producing normal broods; how-
ever, it is significantly defective in embryonic function
where, although it is approximately similar in abundance to
wild-type LIN-23, it fails to down-regulate CDC-25.1 and
also causes 75% embryonic lethality. Finally, we found
that the LIN-23 protein is relatively excluded from nuclei
within the germline, but after fertilization its localization is
dynamic and it enters the nuclear compartment late in the
cell cycle before cell division. Although none of this consti-
tutes proof of the existence of a molecular mechanism that
alters the relative behavior of LIN-23 and CDC-25.1 during
transit from the germline to embryonic states, in combina-
tion these behaviors constitute significant circumstantial ev-
idence that LIN-23 functions differently in the embryo com-
pared with the germline. The postfertilization selective
degradation of CDC-25.1 is reminiscent of a variety of C.
elegans proteins whose degradation is activated during the
oocyte to embryo transition by the MBK-2/DYRK kinase
(Pellettieri et al., 2003). Its targets include OMA-1, also in-
volved in the regulation of the oocyte to embryo transition,
and in addition to MBK-2 phosphorylation, timely degrada-
tion of OMA-1 also requires the function of the kinases
GSK3, CDK-1, and KIN-19 (Shirayama et al., 2006). Both
MBK-2 and GSK3 have been shown to phosphorylate di-
rectly OMA-1 (Nishi and Lin, 2005). Our data suggest GSK3
is not the kinase that targets CDC-25.1 for selective destruc-
tion through the DSG motif because unlike OMA-1, gsk-
3(RNAi) does not stabilize the CDC-25.1 protein; in fact, if
anything it reduces its abundance. In addition, LIN-23 itself
could be subject to developmental regulation. Our observa-
tion that the lin-23::FLAG-TY (ijIs18) transgene completely
complements the germline defect of the lin-23(e1833) null,
but only partially complements its embryonic functions,
might suggest biochemically distinct functions for LIN-23 in
the germline and the embryo. Also, whether the dynamic
behavior of LIN-23 in embryonic blastomeres, shuttling be-
tween the cytosol and chromatin in a cell cycle dependent
manner, relates to its regulated degradation of CDC-25.1 is
not known but is certainly worthy of investigation.
CDC-25.1 function is required positively for cell cycle
progression in many and possibly all early C. elegans embry-
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onic cells (Ashcroft et al., 1999; Clucas et al., 2002; Kostic and
Roy, 2002), and LIN-23-regulated decay of CDC-25.1 prob-
ably occurs in all early embryonic cells, but hyperplasia by
CDC-25.1 stabilization is specific to the intestine. Also, as we
show here, because lin-23(e1883) homozygous mutants de-
rived from heterozygous mothers have a wild-type number
of intestinal cells in the embryo, maternal LIN-23 must be
sufficient for adequate regulated degradation of CDC-25.1 in
the early embryo; hence, a tissue-specific difference in zy-
gotic lin-23 expression cannot explain the intestinal specific-
ity of the hyperplasia. A key question therefore is what
makes the intestinal cell cycle uniquely sensitive to the abun-
dance of this cell cycle regulator? The early embryonic cell
cycles are rapid, consisting simply of S and M phases and
the time of introduction of Gap phases varies in different
lineages. The first recognized Gap phase is a G2 in the
intestinal lineage from Ea and Ep (Edgar and McGhee, 1988),
resulting in the lengthening of the intestinal cell cycle (Fig-
ure 7A). In addition, a G1 phase at the 16 E cell stage has
been proposed, due to the requirement of the G1-type cyclin
cyd-1 for the final intestinal cell divisions (Boxem and van
den Heuvel, 2001). Abrogation of LIN-23–dependent degra-
dation of CDC-25.1 in the embryo causes two distinct effects
within the intestinal cell lineage; a marked shortening of the
intestinal cell cycle and extra rounds of cell division includ-
ing a fifth cleavage of cells that normally exit the cell cycle
after the fourth cleavage, and a sixth cleavage in some cases.
Thus, during normal development, CDC-25.1 abundance is
rate limiting both with respect to the length of the intestinal
cell cycles and also the number of reiterations of the cycle.
The progressive regulated degradation of CDC-25.1 ulti-
mately becomes a checkpoint terminating the intestinal cell
cycle and regulating the cell number of this single organ. It
is probable that the sensitivity of the intestine to CDC-25.1
abundance, and hence the tissue specificity of the pheno-
type, is linked to the switch to the long intestinal cell cycle
and the presence of Gap phases. Interestingly, the cell cycle
shortening by stabilization of CDC-25.1 in the C. elegans
embryo is not entirely restricted to the intestinal lineage.
Two other cell cycles are reported to be affected, namely,
that of the P4 blastomere which is significantly shortened,
and to a lesser extent that of its sister cell D (Bao et al., 2008).
Like the intestinal cell cycles, both of these are long by
comparison to all other C. elegans embryonic cell cycles that
occupy a similar position within the cell lineage (the same
number of cell divisions from the zygote P0). Also, the
shortening is greater in P4, which has a longer cell cycle than
its sister D. Therefore, CDC-25.1 abundance in the embryo is
limiting the cell cycle length of these long cell cycles but not
the rapid cell cycles that are believed only to consist of S and
M phases.
Interestingly, overexpression of CDC25A and B have been
detected in a wide range of human cancers (Kristjansdottir
and Rudolph, 2004), and an oncogenic potential has been
attributed to CDC25A and B but not C in transformation of
murine fibroblasts (Galaktionov et al., 1995). Intriguingly,
only CDC25A and B are targets of -TrCP through the
DSG/DDG motifs (Busino et al., 2003; Jin et al., 2003). It
would be interesting to know whether the oncogenic poten-
tial of CDC25A and B is mediated via loss of their -TrCP
regulation.
An unexpected outcome of this work was the finding of
the delay in commitment to the intestinal fate in the E
lineage, caused by gsk-3(RNAi). Interpretation of this delay
requires consideration of the findings of Schlesinger et al.
(1999). In the Schlesinger study, laser ablation of all other
cells was used to isolate the E blastomere in gsk-3(RNAi)
embryos and in such 44% failed to generate endoderm.
Instead, E seemed to adopt the fate of its sister cell MS as
indicated by formation of muscle. Importantly, all isolated E
blastomeres that produced mesodermal cells did not pro-
duce endodermal cells; a mixture of fates was never ob-
served. That contrasts with our data where we see a mixture,
with intestine being produced from Ep but nonintestinal fate
cells from Ea. The potentially informative difference is that
our results were obtained from the study of lineages within
intact embryos; the E blastomeres were isolated in the
Schlesinger study and hence allowed to develop in an E cell
autonomous manner. In our findings in all cases the E lin-
eage cell where delayed endoderm specification occurred
(usually Ep) and its parental cell were in physical contact
with a descendant of the Wnt signaling cell P2, or P2 itself.
Taking our findings and those of Schlesinger together, we
suggest that knockdown of gsk-3 by RNAi can cause a sim-
ple E-to-MS fate transformation when the source of the
posterior signal is removed, but in intact embryos where the
signal persists, it can cause a delay by one or two cell
divisions to commitment to the intestinal fate in cells of the
E lineage. How might such a delay be generated? The win-
dow of time in which the wild-type EMS blastomere and its
descendants can respond to the P2 posterior signal and in
which P2 and its descendants can produce the signal, has
been investigated (Goldstein, 1995). In the wild-type em-
bryo, the capacity to respond to the P2-derived signal per-
sists for only 6 min in EMS and the daughters of EMS
cannot respond. Conversely, the P2 signal was shown to
persist much longer for up to two cell divisions; hence, a
source of signal is present later. We suggest that gsk-
3(RNAi) must cause a delay to the period of responsive-
ness to the P2 signal within cells derived from EMS. It
would be interesting to determine whether the E blas-
tomere in such cases is truly pluripotent like its normal
parent cell EMS and hence if gsk-3(RNAi) is promoting a
pluripotent state in this lineage.
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